A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia
- 1 February 1978
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 8 (1), 59-70
- https://doi.org/10.1017/s0033291700006632
Abstract
Synopsis: Evidence from a controlled, comparative trial indicates that oral pimozide is clinically at least as effective as depot injections of fluphenazine decanoate in the continuation therapy of a group of schizophrenic patients discharged from hospital. The administration of pimozide was associated with fewer unwanted effects. The implications of the findings are discussed.Keywords
This publication has 21 references indexed in Scilit:
- The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazinePsychological Medicine, 1978
- Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted SchizophrenicsArchives of General Psychiatry, 1977
- Treatment AdherenceThe British Journal of Psychiatry, 1976
- Postpsychotic Depression in SchizophreniaArchives of General Psychiatry, 1976
- Observations on the Dose Regime of Fluphenazine Decanoate in Maintenance Therapy of SchizophreniaThe British Journal of Psychiatry, 1975
- Side effects of depot fluphenazinesComprehensive Psychiatry, 1974
- Influence of Selection of Patients on Results of Clinical TrialsBMJ, 1973
- Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind PlaceboBMJ, 1973
- THE CONTRIBUTION OF FLUPHENAZINE ENANTHATE AND DECANOATE IN THE PREVENTION OF READMISSION OF SCHIZOPHRENIC PATIENTSActa Psychiatrica Scandinavica, 1971
- Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine InjectionBMJ, 1969